🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative findings that clarify how the body's defense network attacks harmful infections while protecting the body's own cells.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this accolade.

The research identified unique "security guards" within the defense system that remove malfunctioning defense cells capable of attacking the body.

The findings are now paving the way for new therapies for immune disorders and malignancies.

These winners will divide a monetary award valued at 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for comprehending how the body's defenses operates and the reason we do not all develop serious self-attack conditions," stated the head of the award panel.

This team's research explain a fundamental mystery: In what way does the immune system defend us from countless invaders while keeping our healthy cells unharmed?

Our body's protection system employs immune cells that search for signs of disease, including pathogens and bacteria it has never encountered.

These defenders employ sensors—known as recognition units—that are produced by chance in a vast number of variations.

That gives the defense network the ability to combat a broad range of threats, but the unpredictability of the process unavoidably creates immune cells that can target the body.

Protectors of the Immune System

Researchers earlier understood that some of these harmful white blood cells were eliminated in the thymus—the site where immune cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the immune system's "security guards"—which patrol the system to neutralize other immune cells that assault the healthy cells.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "The findings have established a new field of research and spurred the creation of new treatments, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs block the body from fighting the tumor, so research are aimed at lowering their numbers.

For autoimmune diseases, experiments are exploring increasing T-reg cells so the body is not being harmed. A comparable method could also be useful in minimizing the chances of transplanted organ rejection.

Pioneering Studies

Professor Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, causing self-attack conditions.

The researcher demonstrated that injecting immune cells from healthy animals could prevent the disease—implying there was a system for preventing immune cells from harming the host.

Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in mice and people that led to the discovery of a gene vital for the way T-regs function.

"Their pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the body's own tissues," said a prominent physiology expert.

"The work is a remarkable example of how basic physiological study can have broad consequences for human health."